Center for Scientific Review; Notice of Closed Meetings, 85222-85223 [2024-24882]

Download as PDF ddrumheller on DSK120RN23PROD with NOTICES1 85222 Federal Register / Vol. 89, No. 207 / Friday, October 25, 2024 / Notices Contact Person: Joann Wu Shortt, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–3333, shorttjw@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Radiation Therapy, Radiation Biology and Nanoparticle Based Therapeutics. Date: November 14–15, 2024. Time: 10:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Jennifer Ann Sanders, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496–3553, jennifer.sanders@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Infectious Diseases and Immunology B Review Panel. Date: November 14–15, 2024. Time: 10:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Diana Maria Ortiz-Garcia, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–5614, diana.ortiz-garcia@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Molecular Bacterial Pathogenesis and Host Defense. Date: November 14, 2024. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Joshua D. Powell, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–5370, josh.powell@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Bioengineering, Biomaterials, and Instrumentation. Date: November 14–15, 2024. Time: 10:00 a.m. to 8:40 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Joseph Thomas Peterson, Ph.D., Scientific Review Office, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118, VerDate Sep<11>2014 17:40 Oct 24, 2024 Jkt 265001 MSC 7814, Bethesda, MD 20892, 301–408– 9694, petersonjt@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Respiratory, Cardiac, and Circulatory Sciences. Date: November 14, 2024. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Eugene Carstea, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4130, MSC 7818, Bethesda, MD 20892, (301) 408– 9756, carsteae@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Endocrinology, Metabolism, and Reproduction. Date: November 14–15, 2024. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Baskaran Thyagarajan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 800B, Bethesda, MD 20892, (301) 867–5309, thyagarajanb2@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–RM– 24–007, SCGE Phase II, Assays and Technologies for Genome Editing. Date: November 14, 2024. Time: 2:30 p.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Karobi Moitra, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480–6893, karobi.moitra@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 22, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–24880 Filed 10–24–24; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Board of Scientific Counselors, National Cancer Institute, November 4, 2024, 10 a.m. to November 4, 2024, 4:40 p.m., National Institute of Health, Building 31, C Wing, 6th Floor, Conference Room C, 9000 Rockville Pike, Bethesda, MD 20892 which was published in the Federal Register on October 1, 2024, FR Doc 2024–22437, 89 FR 79937. This meeting notice is being amended to change the meeting format from hybrid to virtual. The meeting is partially Closed to the public. Dated: October 21, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–24876 Filed 10–24–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Epidemiology and Population Health. Date: November 20, 2024. Time: 10 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Cynthia C. McOliver, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of E:\FR\FM\25OCN1.SGM 25OCN1 ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 89, No. 207 / Friday, October 25, 2024 / Notices Health, 6701 Rockledge Drive, Room 1007G, Bethesda, MD 20892, (301) 594–2081 mcolivercc@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; BBBT Small Business: Biomaterials, Delivery, and Nanotechnology. Date: November 21–22, 2024. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: David R. Filpula, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD 20892, 301–435– 2902, filpuladr@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Clinical Neurophysiology, Devices, Neuroprosthetics and Biosensors. Date: November 21–22, 2024. Time: 8:30 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Cristina Backman, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5211, MSC 7846, Bethesda, MD 20892, (301) 480– 9069, cbackman@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Aging and Development, Auditory Vision and Low Vision Technologies. Date: November 21–22, 2024. Time: 9 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Barbara Susanne Mallon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480–8992 mallonb@ mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Health Services Research, Maternal and Child Health, Aging, and Substance Use. Date: November 21–22, 2024. Time: 9 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Deborah Leachman Quesenberry, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (423) 747–7534, quesenberrydl@csr.nih.gov. VerDate Sep<11>2014 17:40 Oct 24, 2024 Jkt 265001 Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Transformative Research Award for the Include Project. Date: November 21, 2024. Time: 9 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Katherine M. Malinda, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 20892, (301) 435– 0912 malindakm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Substance Use and Prevention and Treatment of Addiction. Date: November 21, 2024. Time: 9 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Jacinta Bronte-Tinkew, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD 20892, (301) 806– 0009, Jacinta.bronte-tinkew@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 22, 2024 Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–24882 Filed 10–24–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 85223 applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; NINDS R35 Review Panel A. Date: November 20–21, 2024. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications and/or proposals. Address: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 20852. Meeting Format: In Person and Virtual Meeting. Contact Person: Tatiana Pasternak, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Boulevard, Rockville, MD 20852, (301) 496– 9223, tatiana.pasternak@nih.gov. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; NINDS R35 Review Panel B. Date: November 20–21, 2024. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 20852. Meeting Format: In Person and Virtual Meeting. Contact Person: Ernest Lyons, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Boulevard, Rockville, MD 20852, 301–496– 4056, lyonse@ninds.nih.gov. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; R13 Review. Date: November 21–22, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Meeting Format: Virtual Meeting. Contact Person: Li Jia, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS/ NIH/DHHS, NSC, 6001 Executive Boulevard, Rockville, MD 20852, 301 451–2854, li.jia@ nih.gov. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Development and Validation of Human Cellular Models for ADRD. Date: November 21, 2024. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Meeting Format: Virtual Meeting. Contact Person: Mirela Milescu, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Boulevard, Rockville, MD 20852, 301–496– 9223, mirela.milescu@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research E:\FR\FM\25OCN1.SGM 25OCN1

Agencies

[Federal Register Volume 89, Number 207 (Friday, October 25, 2024)]
[Notices]
[Pages 85222-85223]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24882]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Epidemiology and Population Health.
    Date: November 20, 2024.
    Time: 10 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Cynthia C. McOliver, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of

[[Page 85223]]

Health, 6701 Rockledge Drive, Room 1007G, Bethesda, MD 20892, (301) 
594-2081 [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; BBBT Small Business: Biomaterials, Delivery, and 
Nanotechnology.
    Date: November 21-22, 2024.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: David R. Filpula, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD 
20892, 301-435-2902, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Clinical Neurophysiology, Devices, 
Neuroprosthetics and Biosensors.
    Date: November 21-22, 2024.
    Time: 8:30 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Cristina Backman, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5211, MSC 7846, Bethesda, MD 
20892, (301) 480-9069, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Aging and Development, Auditory Vision and 
Low Vision Technologies.
    Date: November 21-22, 2024.
    Time: 9 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Barbara Susanne Mallon, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-8992 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Topics in Health Services Research, Maternal and Child 
Health, Aging, and Substance Use.
    Date: November 21-22, 2024.
    Time: 9 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Deborah Leachman Quesenberry, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (423) 747-7534, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Transformative Research Award for the Include 
Project.
    Date: November 21, 2024.
    Time: 9 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Katherine M. Malinda, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 
20892, (301) 435-0912 [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Substance Use and Prevention and Treatment of Addiction.
    Date: November 21, 2024.
    Time: 9 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Jacinta Bronte-Tinkew, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD 
20892, (301) 806-0009, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 22, 2024
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-24882 Filed 10-24-24; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.